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hyroid hormone 3,5,3
 
 
 
-tri-iodothyronine (T
 
3
 
) binds
and activates thyroid hormone receptors (TRs).
Here, we present evidence for a nontranscriptional
regulation of Ca
 
2
 
 
 
 signaling by T
 
3
 
-bound TRs. Treatment
of 
 
Xenopus
 
 thyroid hormone receptor beta subtype A1
(xTR
 
 
 
A1) expressing oocytes with T
 
3
 
 for 10 min increased
inositol 1,4,5-trisphosphate (IP
 
3
 
)-mediated Ca
 
2
 
 
 
 wave
periodicity. Coexpression of TR
 
 
 
A1 with retinoid X receptor
did not enhance regulation. Deletion of the DNA binding
domain and the nuclear localization signal of the TR
 
 
 
A1
eliminated transcriptional activity but did not affect the
ability to regulate Ca
 
2
 
 
 
 signaling. T
 
3
 
-bound TR
 
 
 
A1 regu-
T
 
lation of Ca
 
2
 
 
 
 signaling could be inhibited by ruthenium
red treatment, suggesting that mitochondrial Ca
 
2
 
 
 
 up-
take  was required for the mechanism of action. Both
xTR
 
 
 
A1 and the homologous shortened form of rat TR
 
 
 
1
(rTR
 
 
 
 
 
F1) localized to the mitochondria and increased
O
 
2
 
 consumption, whereas the full-length rat TR
 
 
 
1 did
neither. Furthermore, only T
 
3
 
-bound xTR
 
 
 
A1 and rTR
 
 
 
 
 
F1
affected Ca
 
2
 
 
 
 wave activity. We conclude that T
 
3
 
-bound
mitochondrial targeted TRs acutely modulate IP
 
3
 
-mediated
Ca
 
2
 
 
 
 signaling by increasing mitochondrial metabolism
independently of transcriptional activity.
 
Introduction
 
Thyroid hormones are lipophilic ligands composed of two iodi-
nated tyrosine residues that regulate cellular differentiation and
development, cardiac function, and basal metabolism (Abbatic-
chio et al., 1981; Oppenheimer et al., 1987, 1994; Nagai et al.,
1989; Kawahara et al., 1991; Soboll, 1993a; Ichikawa and
Hashizume, 1995). Thyroid receptors (TRs) are classified as
steroid hormone receptors and have genomic effects similar to
other nuclear receptors such as glucocorticoid, estrogen, and
androgen receptors. Two separate genes encode thyroid hor-
mone receptors 
 
 
 
 (TR
 
 
 
) and 
 
 
 
 (TR
 
 
 
). Alternative splicing or
the use of different promoters generates multiple isoforms in-
cluding the 
 
 
 
 (TR
 
 
 
1, TR
 
 
 
2) and 
 
 
 
 (TR
 
 
 
1, TR
 
 
 
2) subtypes
(Lazar, 1993). Thyroid hormones have been shown to increase
the number of mitochondria and to induce the expression of
mitochondrial proteins encoded by both nuclear and mitochon-
drial genes (Das and Harris, 1991; Soboll, 1993a; Iglesias et
al., 1995; Wrutniak et al., 1995; Meehan and Kennedy, 1997;
Schonfeld et al., 1997). Isolated mitochondria from hyperthyroid
cells exhibit enhanced substrate cycling and increased oxygen
(O
 
2
 
) consumption (Soboll, 1993b). Thyroid hormone also affects
the mitochondrial membrane potential (
 
  
 
) through the ex-
pression of mitochondrial proteins (Soboll, 1993a,b). Collec-
tively, these long-term effects take days or weeks to manifest
and are thought to be mediated by nuclear and mitochondrial
transcriptional regulation.
Increasing evidence suggests that thyroid hormone exerts
nontranscriptional effects on mitochondrial metabolism. Initial
studies demonstrated that treatment of cells with 3,5,3
 
 
 
-tri-
iodothyronine (T
 
3
 
) results in a rapid increase in O
 
2
 
 consumption
and ATP production in rat liver mitochondria (Sterling, 1980).
These effects persisted in the presence of protein synthesis
inhibitors, suggesting that the mechanism of action was non-
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T
 
3
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Xenopus
 
 thyroid
hormone receptor beta subtype A1. 
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transcriptional. Sterling and coworkers (Sterling, 1980; Ster-
ling and Brenner, 1995) additionally demonstrated that exposure
of mitochondria to T
 
3
 
, isolated from rat hepatocytes, increased
both ATP production and O
 
2
 
 consumption. Acute exposure of
isolated mitochondria to thyroid hormone has also been reported
to increase 
 
 
 
pH and to increase mitochondrial Ca
 
2
 
 
 
 efflux (Ster-
ling et al., 1980; Crespo-Armas and Mowbray, 1987; Soboll,
1993a). Mitochondrial localization of TRs was originally re-
ported by Sterling and coworkers (Sterling, 1991). Later, Ardail
et al. (1993) identified two high affinity T
 
3
 
 binding proteins in rat
liver mitochondria. Wrutniak et al. (1995) and Casas et al.
(1999) reported the presence of a high affinity (
 
 
 
43 kD) T
 
3
 
binding protein in rat liver mitochondrial matrix extracts, which
was identified as an NH
 
2
 
 terminus shortened form of rat TR
 
 
 
1
(rTR
 
 
 
 
 
F1). The full-length form of the rat thyroid hormone re-
ceptor alpha subtype 1 (rTR
 
 
 
1) is predominantly localized to the
nucleus where it binds to DNA response elements and regulates
transcriptional events (Wrutniak et al., 1995). Wrutniak (Wrut-
niak et al., 1995) suggested that the mitochondrial form of the
rTR may be involved in mitochondrial transcriptional activity.
Intracellular Ca
 
2
 
 
 
 signaling has been intimately linked to
mitochondrial metabolism. Several dehydrogenases within the
citric acid cycle are Ca
 
2
 
 
 
 dependent (McCormack and Denton,
1989). Ca
 
2
 
 
 
 uptake into the mitochondria is a passive process
driven by the mitochondrial 
 
  
 
 and occurs via the Ca
 
2
 
 
 
 uni-
porter. Because of the low Ca
 
2
 
 
 
 affinity of the uniporter, high
cytosolic Ca
 
2
 
 
 
 concentrations are required to cause significant
mitochondrial Ca
 
2
 
 
 
 uptake. Under physiological conditions,
these concentrations only occur near an open ion channel pore.
Consequently, close physical proximity between the ER and
mitochondria is required for significant mitochondrial Ca
 
2
 
 
 
 up-
take (Rizzuto et al., 1998, 1999). Work from our laboratory
also demonstrated that mitochondrial Ca
 
2
 
 
 
 uptake itself modu-
lated inositol 1,4,5-trisphosphate (IP
 
3
 
)-Ca
 
2
 
 
 
 release (Jouaville
et al., 1995). Subsequently, Hajnoczky et al. (1995) demon-
strated that IP
 
3
 
-mediated Ca
 
2
 
 
 
 oscillations efficiently stimu-
lated mitochondrial metabolism. The local Ca
 
2
 
 
 
 signaling be-
tween the ER and mitochondria has now been supported by
many other investigators (Simpson and Russell, 1996; Hajnoc-
zky et al., 1999; Szalai et al., 2000). Control of mitochondrial
metabolism by matrix Ca
 
2
 
 
 
 appears to be a fundamental mech-
anism whereby cells meet their energy requirements.
 
Xenopus laevis
 
 oocytes do not express detectable levels
of endogenous TRs (Banker et al., 1991; Kawahara et al., 1991;
Eliceiri and Brown, 1994). Induction of TR expression in 
 
Xe-
nopus laevis
 
 occurs during the embryonic stages of develop-
ment (Yaoita and Brown, 1990; Banker et al., 1991; Kawahara
et al., 1991; Eliceiri and Brown, 1994). Consequently, 
 
Xenopus
 
oocytes offer a unique model system to study the effects of thy-
roid hormones and their receptors on intracellular Ca
 
2
 
 
 
 signal-
ing and mitochondrial metabolism.
We present evidence demonstrating that thyroid hor-
mone-activated TRs acutely regulate mitochondrial metabolism
and, thereby, Ca
 
2
 
 
 
 wave activity. Only expression of the NH
 
2
 
terminus–truncated forms of TR that target the mitochondria
were effective at stimulating mitochondria. Transcriptionally
inactive TRs were fully capable of modulating Ca
 
2
 
 
 
 wave ac-
tivity. These observations suggest an acute nontranscriptional
pathway for modulation of intracellular Ca
 
2
 
 
 
 signaling via thy-
roid hormone receptor-stimulated mitochondrial metabolism.
 
Results
 
T
 
3
 
-stimulated TR
 
 
 
A1s modulate IP
 
3
 
-
mediated Ca
 
2
 
 
 
 wave activity
 
Acute nongenomic effects of thyroid hormones occur within
minutes of ligand treatment (Hummerich and Soboll, 1989). To
examine the importance of TRs on the nongenomic modulation
of intracellular Ca
 
2
 
 
 
 signaling, stage VI 
 
Xenopus
 
 oocytes were
injected with mRNA encoding the 
 
Xenopus
 
 thyroid hormone
receptor betz subtype A1 (xTR
 
 
 
A1) as described previously
(Camacho and Lechleiter, 2000). Expression of xTR
 
 
 
A1 was
confirmed by Western blot analysis, 2–3 d after mRNA injec-
tion (Fig. 1). The Ca
 
2
 
 
 
 indicator dye was injected into oocytes
30–45 min before confocal imaging. When oocytes were in-
jected with IP
 
3
 
, we observed repetitive Ca
 
2
 
 
 
 wave activity with
interwave periods of 6.62 
 
 
 
 0.20 s (n   70; Fig. 1). When
xTR A1 expressing oocytes were treated with T3 10 min before
IP3 injection, the Ca
2  wave periodicity increased significantly
to 8.40   0.30 s (Fig. 1, a and c; n   24, P   0.0001 ANOVA
single factor). Treatment of oocytes with T3 by itself did not in-
duce Ca
2  release and no detectable changes in basal intracel-
lular Ca
2  concentrations were observed. Application of T3
ligand to nonexpressing control oocytes, had no effect on the
Figure 1.  T3-bound TR A1 increases IP3-induced Ca
2 
wave period. (a) Spatial-temporal stacks of IP3 ( 300 nM)-
induced Ca
2  wave activity in a representative control
(water injected) oocyte, a T3-treated (100 nM) oocyte
expressing TR A1 and a T3 (100 nM) treated oocyte.
Each image is 745   745  m. (b) Western blot showing
expression of TR A1. Protein extracts from all groups
were collected and loaded at 0.5 oocytes per lane onto
10% SDS-PAGE. The membrane was probed with a
monoclonal mouse anti–human TRs antibody (MA1-215)
and labeled with an HRP-conjugated secondary anti-
body. (c) Histogram of average interwave period for
each group of oocytes. n values in parentheses represent
the total number of oocytes pooled from at least two
frogs. Error bars correspond to the mean   SEM. The
asterisks  (**) denote a statistic significant difference
(ANOVA single factor, P   0.0001).NONGENOMIC SIGNALING BY THYROID HORMONE RECEPTOR • SAELIM ET AL. 917
Ca
2  interwave period (6.38   0.34 s, n   27, Fig. 1, a and c).
Similarly, xTR A1 expressing oocytes without T3 treatment
exhibited no change in Ca
2  wave periodicity (6.97   0.24 s,
n   35). Peak Ca
2  wave amplitudes ( F/F) for xTR A1-
expressing oocytes exposed to T3 (0.69   0.04, n   29) was
also significantly higher than that of control oocytes exposed to
T3 (0.55   0.04, n   20; P   0.05, t test). We conclude from
these data that T3-stimulated xTR A1 acutely modulates IP3-
mediated Ca
2  wave activity and that both thyroid hormone
and receptor expression are required for these effects.
Transcriptional activity of TR A1 is 
undetectable in the absence of xRXR
Classically, activated thyroid hormone receptors heterodimer-
ize to initiate transcription responses. Retinoid X receptor
(RXR) is the most common dimerization partner that binds to
the thyroid hormone response element (TRE; Leid et al., 1992;
Bhat et al., 1994; Wong and Shi, 1995). To investigate the tran-
scriptional activity of xTR A1, we coinjected oocytes with
xTR A1 mRNA and a plasmid reporting vector containing a
TRE system with two direct repeats (DR4) upstream of the se-
creted placental alkaline phosphatase (SEAP) gene (p-TRE-
SEAP; CLONTECH Laboratories, Inc.). If the hormone recep-
tor dimerizes and binds to the TRE enhancer, the oocyte
expresses SEAP, which is secreted into the medium. mRNA-
injected oocytes were continuously bathed in T3 (100 nM) for
3 d and the presence of SEAP was subsequently quantified by
Western blot analysis and used as a marker for transcriptional
activity. Using this TRE-reporting system, we observed no
transcriptional activity in oocytes expressing the xTR A1 pro-
tein by itself (Fig. 2 a, lane 3). However, when we coexpressed
xRXR  with xTR A1 and oocytes were incubated with T3 (100
nM) and 9-cis retinoic acid (RA; 100 nM) for 3 d, SEAP ex-
pression was significantly increased (Fig. 2 a, lane 5). Note that
xTR A1/xRXR -mediated transcription requires both ligands,
T3 and RA (Fig. 2 a, lanes 4 and 5). These data indicate that
stimulation of xTR A1 by T3 does not initiate detectable tran-
scription in Xenopus oocytes.
Acute modulation of Ca
2  signaling does 
not require heterodimerization with RXR
To test whether heterodimerization of xTR A1 with xRXR  af-
fects the acute modulation of Ca
2  activity, we coinjected oocytes
with both xRXR  and xTR A1 mRNA and confirmed protein ex-
pression levels using Western analysis 2–3 d after injection
of mRNA (Fig. 3 b). Oocytes were loaded with Ca
2  indicator
dye and confocally imaged. Oocytes coexpressing xTR A1 and
Figure 2.  Transcriptional activity of TR A1 requires xRXR  and both
cognate ligands. Transcriptional activity was monitored with the TRE-reporter
vector, pSEAP 
(TRE). (a) Lanes 1 and 2 are negative (pSEAP
( ve)) and posi-
tive (pSEAP
( ve)) vector controls. Oocytes expressing TR A1 or TR A1 plus
xRXR  were incubated with 100 nM T3 (lanes 3–5) plus 100 nM RA (lane 5)
for 3 d. Cytosolic extracts from each group of oocytes was prepared and
loaded onto a 10% SDS-PAGE at 2.5 oocytes equivalents per lane. SEAP
was detected with the polyclonal rabbit anti–human SEAP antibody and
an HRP-conjugated secondary antibody. The SP labeled arrow indicates
SEAP immunoreactivity, which was present only in oocytes expressing
TR A1 and xRXR  exposed to both T3 and RA. (b) Transcriptional activity
of TR A1 requires the pBOX within the DBD and the NLS. Oocytes ex-
pressing xTR A1 pBox-NLS and xRXR  show no SEAP immunoreactivity
when incubated with T3 (lane 6) or T3 plus RA (lane 7). Western blot
analysis shows that xRXR , TR A1, and xTR A1 pBox-NLS are expressed
at comparable levels (Western blots below lanes 4–7). TR A1 and
xTR A1 pBox-NLS were detected with the monoclonal mouse anti–human
TRs antibody (MA1-215). xRXR  was detected with a polyclonal rabbit
anti–human RXR antibody (Sc-774).
Figure 3.  Acute modulation of Ca
2  signaling does
not require heterodimerization of TR A1 with xRXR .
(a) Spatial-temporal stacks of IP3-induced Ca
2  wave ac-
tivity in control oocytes compared with oocytes expressing
TR A1 or TR A1 with xRXR . T3 (100 nM) and RA (100 nM)
were added as indicated 10–15 min before injection
with IP3 (  300 nM). Scale is the same as Fig. 1. (b)
Western blots of oocytes expressing TR A1 and xRXR .
Primary and secondary antibodies were identical to those
used in Figs. 1 and 2. (c). Histogram of average inter-
wave period (second) of each group of oocytes. The as-
terisks (**) denote a statistic significance using ANOVA
single factor (P   0.0001). Values in parentheses repre-
sent the number of oocytes.JCB • VOLUME 167 • NUMBER 5 • 2004 918
xRXR  were initially exposed to both T3 (100 nM) and RA (100
nM) 10 min before injection with IP3 ( 300 nM). The average
Ca
2  interwave period for xTR A1-expressing oocytes was 6.58  
0.26 s (n   67), whereas that of xRXR /xTR A1 coexpressing
oocytes was 6.72   0.31 s (n   82; Fig. 3, a and c). These values
were not significantly different from each other (P   0.22), but
were both significantly larger than values in the control oocytes
that exhibited an average Ca
2  interwave period of 5.90   0.43 s
(n   55, ANOVA single factor, P   0.0001; Fig. 3, a and c). We
conclude that the xRXR  coexpression does not affect the ability
of T3-bound xTR A1 to modulate Ca
2  signaling.
The DNA binding domain and NLS of 
TR A1 are not required for acute affects 
on Ca
2  signaling
The ability of T3-bound xTR A1 to rapidly modulate Ca
2  ac-
tivity suggested a nontranscriptional mechanism of action.
Our strategy to test this hypothesis was to delete the DNA
binding domain (DBD) and mutate the NLS from the thyroid
hormone receptor and test whether the mutant receptors were
(a) transcriptionally inactive and (b) still effective at modulat-
ing Ca
2  signaling. Oocytes were injected with the p-TRE-SEAP
plasmid reporting vector. This reporting system requires het-
erodimerization of xRXR  and xTR A1 to transactivate the
reporter gene (Fig. 2 a). Consequently, test oocytes were coin-
jected with xRXR mRNA with mRNA encoding either wild-
type xTR A1 (control), mutant xTR A1 lacking the NLS
(xTR A1- NLS), or the mutant lacking both the NLS and the
pBOX (xTR A1 pBox-NLS). Once injected, oocytes were
continuously bathed in T3 (100 nM) and RA (100 nM) for 3 d.
Expression levels of xTR A1 mutants and xRXR  groups
were comparable to xTR A1 and xRXR  groups (Fig. 2 b, bot-
tom). Using the expression of SEAP as a marker for tran-
scriptional activity, we confirmed that oocytes expressing the
xTR A1 mutants and xRXR  proteins were transcriptionally
inactive, whereas oocytes expressing wild-type xTR A1 and
xRXR  proteins exhibited strong transcriptional activity (Fig.
2, lanes 7 and 5).
Subsequently, we tested whether the transcriptionally inac-
tive xTR A1 mutants could still acutely regulate Ca
2  signaling.
Oocytes were injected with xTR A1 mRNA or its mutants and
protein expression levels were confirmed using Western analysis
2–3 d after injection (Fig. 4 c). Oocytes expressing xTR A1 or
the mutants were exposed to T3 (100 nM) 10 min before injec-
tion with IP3 ( 300 nM). Ca
2  activity was confocally imaged,
as described above. The average Ca
2  interwave period for the
control group (water-injected oocytes) was 6.6   0.20 s (n  
70), which was significantly shorter than that in the xTR A1 ex-
pressing oocytes (8.40   0.30 s, n   40; ANOVA single factor,
P   0.0001; Fig. 4 b, d; Fig. 1. More importantly, regulation of
the Ca
2  wave period in oocytes expressing either the single mu-
tant xTR A1- NLS (9.6   0.48 s, n   24) or the double mutant,
xTR A1 pBox-NLS (8.4   0.28 s; n   24) was indistinguish-
able from oocytes expressing wild-type xTR A1 (Fig. 4, b and
d). We conclude from these data that neither the pBOX nor the
NLS of TR A1 is required for acute regulation of Ca
2  signaling.
T3-bound TR A1 appears to regulate Ca
2  
signaling by increasing mitochondrial 
respiration
We reported previously that pyruvate/malate-energized mito-
chondria increase the amplitude and interwave period of IP3-
induced Ca
2  waves in Xenopus oocytes (Jouaville et al., 1995).
These effects on Ca
2  wave activity were similar to those ob-
served in TR A1 overexpressing oocytes with acute T3 incuba-
tion (Fig. 1). Sterling and colleagues (Sterling, 1980) initially
reported that T3 increases mitochondrial metabolism, particu-
larly oxidative phosphorylation, in less than 30 min. Conse-
quently, we hypothesized that the regulation of Ca
2  signaling
by T3-activated xTR A1 was mediated by its acute modulation
of mitochondrial metabolism, which, in turn, increased mito-
chondrial Ca
2  uptake. Our strategy to test this hypothesis was
threefold. First, we examined the effect of T3 on    in TR A1
expressing oocytes using the potential sensitive dye tetrameth-
ylrhodamine ethyl ester (TMRE). Oocytes were bathed in 200
nM TMRE for 5 min before imaging fluorescence with two-
Figure 4. The pBOX and NLSs of TR A1 are not required
for the acute regulation of Ca
2  signaling. (a) Schematic
figure depicting the position of the pBOX deletion in the
DBD and the NLS modification within TR A1. (b) Spatial-
temporal stack of IP3-induced Ca
2  wave activity in con-
trol oocytes compared with oocytes expressing TR mutants
 pBox-NLS and  NLS. Oocytes expressing the TR mutants
were incubated with T3 (100 nM) 10–15 min before IP3
( 300 nM) injections. (c) Western blot analysis confirming
comparable levels of protein expression for both wild-
type and mutant TR A1. (d) Histogram of the average
Ca
2  wave periods for each group of oocytes (n values
are in parentheses). Statistic significance over control
oocytes is indicated by the asterisks (**; ANOVA single
factor, P   0.0001).NONGENOMIC SIGNALING BY THYROID HORMONE RECEPTOR • SAELIM ET AL. 919
photon excitation (800 nm).    was estimated by monitoring
Log(Fmito/Fcyto) where Fmito is the fluorescence intensity of indi-
vidual mitochondria and Fcyto is the cytosolic fluorescence (Far-
kas et al., 1989). We found that T3 significantly increased   
from a resting value of 0.33   0.01 (n   75) to 0.44   0.01
(n   92, P   0.0001) at 5 min and to 0.48   0.02 (n   48, P  
0.0001) at 25 min (Fig. 5). These data suggest that T3-bound
TR A1 regulates Ca
2  signaling by increasing   . Second, we
injected a subgroup of the TR A1-expressing oocytes with ru-
thenium 360 (Ru360; Calbiochem,  1  M final concentration),
a polycation that inhibits the electrogenic mitochondrial Ca
2 
uniporter (Ying et al., 1991)  60 min before IP3 injection and
Ca
2  imaging. A control group of TR A1-expressing oocytes
were injected with buffer only. We found that Ru360 treatment
completely inhibited the affect of T3-bound TR A1 on Ca
2 
wave activity (Fig. 6). Untreated TR A1 expressing oocytes
exhibited the expected increase in wave periodicity (7.65   0.4 s,
n   11) when preexposed to T3 for 10 min. However, the av-
erage wave period of Ru360-treated TR A1 expressing oocytes
was only 5.75   0.22 s (n   13) when preexposed to T3. The
Ru360-treated average was nearly identical to untreated control
oocytes (5.59   0.04 s, n   4) as well as Ru360-treated nonex-
pressing oocytes (5.53   0.4 s, n   3). These data are consis-
tent with the hypothesis that T3-bound TR A1 regulates Ca
2 
signaling by increasing mitochondrial Ca
2  uptake via an in-
crease in   .
Third, we directly test whether thyroid hormone receptor
together with T3 stimulates mitochondrial respiration. Xenopus
oocytes were injected with TR A1 mRNA or water and incu-
bated for 3 d. The rate of O2 consumption was measured as an
indicator of respiration. 200 oocytes in each group were loaded
into a 2-ml O2 probe chamber filled with modified barth’s solu-
tion (MBS) solution. After 15 min of stabilization, the medium
was exchanged with fresh MBS and O2 consumption was mon-
itored for 30 min. The medium was exchanged a third time with
MBS containing 100 nM T3 and O2 consumption was followed
for another 30 min (Fig. 7, a and b). After this protocol, the rate
of O2 consumption in water-injected oocytes after T3 exposure
was 0.42   0.25 nmol/min (n   8). In contrast, the rate of O2
consumption in TR A1-injected oocytes after T3 exposure was
significantly increased to 1.68   0.52 nmol/min (n   4, P  
0.05). These data support the hypothesis that a T3 / TR A1-
mediated increase in mitochondrial respiration was responsible
for the modulation of IP3-mediated Ca
2  wave activity.
TRs targeted to the mitochondria are 
required for a T3-stimulated increase in 
respiration and the regulation of Ca
2  
signaling
T3 treatment has previously been reported to increase mito-
chondrial metabolism (Sterling et al., 1980; Soboll, 1993a).
Figure 5.  T3 stimulation of oocytes expressing TR A1 increases the   .
(a) Images of mitochondria labeled with the potential sensitive dye TMRE.
The oocytes are expressing TR A1 and have been exposed to T3 for the
indicated amount of time. Images are 50   100  m. (b) Histogram of the
log of mitochondrial TMRE fluorescence (Fmito) divided by the cytosolic fluo-
rescence (Fcyto) at the indicated times of T3 exposure. Values in parentheses
refers to the number of mitochondrion analyzed. Statistical significance is
indicated by the asterisks (**; ANOVA single factor, P   0.001).
Figure 6.  Ru360 blocks T3-bound TR A1 increases in IP3-
induced Ca
2  wave period. (a) Spatial-temporal stacks of
the effect of Ru360 treatment on Ca
2  wave activity in
control oocytes compared with oocytes expressing
TR A1as labeled. (b) Histogram of average interwave
period (seconds) of each group of oocytes shown in a.
The asterisk (*) denotes a statistic significance using
ANOVA single factor (P   0.01). Values in parentheses
represent the number of oocytes.JCB • VOLUME 167 • NUMBER 5 • 2004 920
Our data suggest that the acute effects of T3 on mitochon-
drial metabolism are likely to be mediated by T3-activated
thyroid hormone receptors. A truncated form of rat TR 1
(rTR 1 F) has been shown to localize to mitochondria ma-
trix (Ardail et al., 1993; Wrutniak et al., 1995; Casas et
al., 1999). Furthermore, the NH2 terminus of the Xenopus
TR A1 that we used throughout this work has a high homol-
ogy to the NH2 terminus of rTR 1 F (Fig. 8 a). Our strategy
in this experiment was to test whether mitochondrial target-
ing of TRs was necessary to modulate Ca
2  signaling. First,
we examined the cellular targeting of xTR A1, rTR 1, and
rTR 1 F by injecting Xenopus oocytes with their respective
mRNAs. After 3 d of expression, mitochondria were isolated
by centrifugation. Whole oocyte extract (minus mitochon-
dria) and mitochondrial extract from each group were sub-
jected to immunoprecipitation using a TR antibody (MA1-
215; Affinity BioReagents, Inc.). The immunocomplexes
(TRs/MA1-215) were loaded onto a 10% SDS-PAGE gel for
Western blot analysis. As shown in Fig. 8 c, only xTR A1
and rTR 1 F were detected in the mitochondria extracts.
Full-length rTR 1 did not localize to mitochondria. These re-
sults are consistent with previous reports (Ardail et al., 1993;
Wrutniak et al., 1995; Casas et al., 1999). Our next step
was to compare the rate of O2 consumption for oocytes ex-
pressing either rTR 1 or rTR 1 F (Fig. 9). Consistent with
its mitochondrial targeting, the rate of O2 consumption in
rTR 1 F expressing oocytes after T3 exposure was signifi-
cantly increased 1.88   0.35 nmol/min (n   3, P   0.05). In
contrast, the rate of O2 consumption in oocytes expressing
the full-length rTR 1 was not significantly affected by T3 ex-
posure ( 0.16   0.55, n   3). We conclude that mitochon-
drial targeting of TRs is required for a T3 mediated increase
in mitochondrial respiration.
Finally, we tested whether targeting of TRs to mitochon-
dria was required to regulate Ca
2  signaling. As before, oo-
cytes were injected with either full-length rTR 1 or NH2 termi-
nus–truncated rTR 1 F mRNAs. Protein expression levels
were measured 2–3 d after injection (Fig. 10 b). Ca
2  activity
was confocally imaged 10 min after treatment with T3 (100 nM).
We found that the average Ca
2  interwave period for rTR 1 F-
injected oocytes was 8.8   0.26 s (n   24), which was signifi-
cantly higher (ANOVA single factor, P   0.01) than full-
length rTR 1-expressing oocytes (7.9   0.38 s, n   22) and the
water-injected control group (7.2   0.24 s; n   30; Fig. 10, a
and c). Together, these data strongly indicate that the regula-
tion of Ca
2  signaling by T3-activated TRs requires their local-
ization within mitochondria.
Figure 7.  T3 stimulation of oocytes expressing TR A1 increases O2
consumption. (a) Plots of O2 levels in oocytes as labeled (n   200 oocytes
per group). (b) Histogram represents average change of O2 consumption
rates (before and after T3 exposure) in control and xTR A1 groups. Statistical
significance is indicated by the asterisk (*; t test, P   0.05).
Figure 8.  Xenopus TR A1 and NH2-terminal truncated rat TR 1
(rTR 1 F) localize to mitochondria. (a) Schematic diagram of TRs showing
that rTR 1 F and xTR A1 have a similar NH2 terminus. (b and c) Western
blots of TR 1, rTR 1 F, and xTR A1 expression in whole oocytes and mito-
chondrial extracts respectively. FL, full-length receptor; SH, shortened form
of the receptor. Extracts were prepared from 300 oocytes in each group.
All oocytes were exposed to 100 nM T3 for at least 15 min before organelle
extraction. TRs were immunoprecipitated with a monoclonal mouse anti–
human TRs antibody (MA1-215), captured with immobilized protein G,
concentrated, and loaded onto a 10% SDS-PAGE. An HRP-conjugated
secondary antibody was used for visualization.
Figure 9.  NH2-terminal truncated rat TR 1 (rTR 1 F) stimulates O2
consumption. (a) Plots of O2 levels for oocytes expressing full-length rTR 1
with and without T3 compared with oocytes expressing the NH2-terminal
truncated rTR 1 F with or without T3. Protocols used were identical to
those described in Fig. 7. (b) Histogram of the average change of the O2
consumption rates after T3 exposure in rTR 1 versus rTR 1 F groups. The
asterisk (*) indicates statistical significance (t test, P   0.05).NONGENOMIC SIGNALING BY THYROID HORMONE RECEPTOR • SAELIM ET AL. 921
Discussion
In this work, we report that the acute exposure of oocytes ex-
pressing mitochondrially targeted TR to T3 regulates IP3-medi-
ated Ca
2  wave activity. We observed a T3-bound TR induced
increase in the Ca
2  wave period and amplitude. These changes
in Ca
2  activity were similar to those observed in Xenopus oo-
cytes when mitochondria were energized with respiratory chain
substrates (Jouaville et al., 1995). In that report, the modulation
of IP3-mediated Ca
2  release was due to an increase in mito-
chondrial Ca
2  uptake via an increase in the   . Our current
work is consistent with this model because we could inhibit the
effects of T3-bound TRs by inhibiting mitochondrial Ca
2  up-
take with Ru360. We also directly demonstrated that T3 expo-
sure increased    in oocytes expressing TRs. An increase in
   could be attributed to either a direct effect on electron
transport or to a decrease in proton leak (Gunter and Pfeiffer,
1990; Gunter and Gunter, 1994; Gunter et al., 1998). The appli-
cation of T3 to mitochondria has been reported to decrease pro-
ton leak in several preparations (Crespo-Armas and Mowbray,
1987; Soboll, 1993a). However, we found that T3 exposure in-
creases O2 consumption in TR-expressing oocytes. An increase
in the rate of O2 consumption is not consistent with a decrease
in proton leak. Together, our data favors the conclusion that T3-
bound TR regulates Ca
2  activity by increasing    via an in-
crease in proton pumping by the respiratory chain.
Application of thyroid hormones to mitochondria has long
been known to increase metabolism (Sterling, 1980). Mitochon-
dria were also known to be target organelles of T3 accumulation
in cells (Sterling et al., 1984; Morel et al., 1996). However, a
mitochondrial hormone receptor that mediated these effects has
never been conclusively identified. Sterling (1986, 1991) ini-
tially suggested that the adenine nucleotide translocator (ANT)
bound to T3 with high affinity. Romani et al. (1996) also sug-
gested that thyroid hormone had its specific mitochondrial tar-
get site at the matrix side of ANT. They found that bongkrekic
acid, a membrane-permeant inhibitor of ANT, blocked a thyroid
hormone-induced release of Mg
2  from mitochondria. On the
other hand, Wrutniak and coworkers (Wrutniak-Cabello et al.,
2001) found no evidence demonstrating a direct interaction be-
tween ANT and T3. Our data indicate that ANT alone is not the
thyroid hormone receptor that mediates the regulation of mito-
chondrial metabolism. Rather, our data reveal that a mitochon-
drial targeted TR is a required element of acute thyroid hor-
mone regulation of metabolism. The use of Xenopus oocytes in
these experiments was crucial in this determination because oo-
cytes do not express endogenous TRs (Yaoita and Brown, 1990;
Kawahara et al., 1991). The ubiquitous expression of endoge-
nous TRs would have hidden this finding in earlier studies.
The ability of specific thyroid hormone receptors to tar-
get mitochondria has been demonstrated by other investigators.
A truncated form of rat TR 1 (rTR 1 F) and not its full-length
form, localized to the matrix of mitochondria (Ardail et al.,
1993; Wrutniak et al., 1995; Casas et al., 1999). Our work
corroborated these reports and further demonstrated that the
xTR A1, which is highly similar to rTR 1 F, targeted the mi-
tochondria. Casas and coworkers (Casas et al., 1999) reported
that mitochondrial activity was stimulated by overexpression
of p43 (mitochondria-targeted, truncated-TR ), which in turn,
stimulated mitochondrial genome transcription of some en-
zyme units that played a role in the respiratory chain. The p43
protein had the same affinity to T3 as the full-length TR  to
bind to the D-loop of two mt-TREs in the mitochondria, lead-
ing to mitochondrial protein synthesis (Casas et al., 1999).
Their data suggested that p43 bound to mt-TREs as a ho-
modimer because no RXR-isoform in the mitochondrial extract
was detected (Casas et al., 1999). Hadzic suggested that the
NH2 terminus of TRs plays a role in TR-homodimerization in
mitochondria (Hadzic et al., 1998). Together, these studies
demonstrated that mitochondrial-targeted TRs could regulate
mitochondrial metabolism by initiating transcription. However,
our results cannot be accounted for by this mechanism of ac-
tion. Specifically, transcriptionally inactive TR mutants modu-
lated Ca
2  wave activity with the same efficacy as the wild
type, xTR A1. We confirmed that xRXR  was required for
xTR A1 to transactivate a reporter gene in our system, but
more importantly, the presence of xRXR did not affect the abil-
ity of xTR A1 to modulate Ca
2  activity. Thus, we concluded
that the mechanism by which T3-activated TRs regulate Ca
2 
signaling cannot be attributed to transcription.
Figure 10.  The truncated rTR 1 F regulates intracellular
Ca
2  release. (a) Spatio-temporal stacks of IP3-induced
Ca
2  wave activity in control oocytes compared with
oocytes expressing rTR 1 F or rTR 1 F. TR expressing
oocytes were treated with 100 nM T3 10–15 min before
IP3 (  300 nM) injections and confocal imaging. (b)
Western blots of rTR 1 and rTR 1 F expression levels in
experimental oocytes. (c) Histogram of the average inter-
wave periods for each group (n values in parentheses).
Note that rTR 1 F has significantly longer periods even
though its expression levels are lower than those of full-
length rTR 1. The asterisks (**) indicate statistical signifi-
cance with P   0.01 using ANOVA single factor.JCB • VOLUME 167 • NUMBER 5 • 2004 922
Nongenomic effects of various steroid receptors have
been reported for mineralocorticoids (Moura and Worcel,
1984; Zhou and Bubien, 2001), glucocorticoids (Borski, 2000;
Borski et al., 2002), gonadal steroids (Pietras and Szego, 1975;
Wasserman et al., 1980; Lieberherr and Grosse, 1994; Guo et
al., 2002a,b; Minshall et al., 2002), vitamin D3 (Sergeev and
Rhoten, 1995), and thyroid hormone (Hummerich and Soboll,
1989; Davis and Davis, 1996, 2002; Rojas et al., 2003). Most of
these studies proposed the presence of specific membrane-
bound receptors for nongenomic effects; however, specific re-
ceptors were not cloned or identified. For thyroid hormones in
particular, Davis and Davis (2002) suggested that the mecha-
nism of the nongenomic effects of thyroid hormone may not re-
quire TRs, and could involve actions of the hormone itself on
signal transduction pathway via specific G protein–coupled
protein. Recent work by Scanlan et al. (2004) identified an en-
dogenous, rapid-acting derivative of thyroid hormone that is a
potent agonist of the G protein-coupled trace amine receptor
(TAR1). Activation of TAR1 increased cAMP production,
which in turn, would active protein kinase A and phosphoryla-
tion of multiple proteins in cells. Our results do not exclude a
potential role of second messenger systems in the mechanism
of action of T3 on mitochondria. Rather, they demonstrate that
classic TRs, those that have long been known to regulate gene
transcription, will also acutely regulate mitochondrial activity
when bound with T3. Stimulation is dependent on mitochon-
drial targeting of the TR, but not on its ability to initiate tran-
scription. Together, these observations reveal a nontranscrip-
tional pathway for modulation of intracellular Ca
2  signaling
via T3/TR-stimulated mitochondrial metabolism.
The discovery of T3/TR-regulated Ca
2  signaling is po-
tentially important for several reasons. First, any process that
acutely regulates intracellular Ca
2  release will impact the mul-
titude of Ca
2 -sensitive cellular processes ranging from con-
tractility and secretion to proteolysis and cell death. Second,
the ability of a steroid hormone to increase proton pumping
provides a rapid method to increase metabolism in response to
short-term energy requirements; for example, during increased
neuronal activity or during a transient increase in muscle activ-
ity. Third, and potentially more importantly, a rapid increase in
mitochondrial Ca
2  uptake could protect cells under conditions
of stress. Mitochondria have long been recognized for their ca-
pacity to sequester large Ca
2  concentrations under pathologi-
cal conditions (Gunter et al., 1994). The ability to transiently
remove Ca
2  from the cytosol could be used to minimize tissue
damage after stroke in neuronal tissue or to reduce the instabil-
ity of cardiac cells after periods of hypoxia. Clearly, the identi-
fication of a mitochondrial receptor for thyroid hormone-induced
increases in metabolism offers a new pharmacological target
from which it will be possible to regulate a broad range of
physiological and pathological processes.
Materials and methods
Expression vector construction
The coding fragments of rat TR 1 cDNA, Xenopus RXR  (a gift from R.M.
Evans, The Howard Hughes Medical Institute, Chevy Chase, MD, and The
Salk Institute for Biological Studies, La Jolla, CA) were amplified by PCR
with a forward primer 5 -acgtggatccatggaacagaagccaagcaaggtg-3  (for
rTR 1), 5 -acgtggatccatgagttcagcagccatggacaccaaacat-3  (for xRXR )
containing a BamHI site, and a reverse primer, 5 -atcgaagcttttagacttcct-
gatcctcaaagacctc-3  (for rTR 1), 5 -atcgaagcttttaagtcatttggtgaggggcttc-
cagcat-3  (for xRXR ) containing a HinDIII site. The PCR products were
then subcloned into the Xenopus oocyte expression vector, pGEM-HeNot
between the BamHI and HinDIII sites (Camacho and Lechleiter, 1995). All
restriction enzymes were purchased from Life Technologies. The truncated
form of rTR    (rTR 1 F) was generated by PCR at the second ORF of rTR 1
cDNA using a forward primer, 5 -acgtggatccatgtcagggtatatccctagttacc-3 
containing a BamHI site, and a reverse primer, 5 -atcgaagcttttagacttcct-
gatcctcaaagacctc-3  containing a HinDIII site. The PCR product was placed
into the pGEM-HeNot vector between the BamHI and HinDIII sites.
Xenopus TR A1 was amplified by PCR with primers 5 -gctaggatc-
catggaagggtatatacccagctacttgg-3  and 5 -atcgaagcttctagtcctcaaacacttc-
caagaacagtggggg-3  and subcloned into vector pGEM-HeNot between
the BamHI and HinDIII sites to create pGEM-HeNot-xTR A1. Xenopus mu-
tant xTR A1- NLS had its NLS removed by modifying the sequence from
KR to AA. xTR A1 pBox-NLS had the same NLS modification as well as
the pBOX deletion of CEGCK within the DBD. Both mutants were gener-
ated by QuikChange site-directed mutagenesis (Stratagene) using pGEM-
HeNot-xTR A1 as a template. The forward primer for xTR A1NLS was 5 -
ggttttggatgacaacgcagctttggcaaaaagaaagc-3  and the reverse complement
primer was 5 -gctttctttttgccaaagctgcgttgtcatccaaaacc-3 . For the double
mutation, pGEM-HeNot-xTR A1NLS was used as a template. The forward
primer for xTR A1 pBox-NLS was 5 -gggtatcattatagatgtatcaccggctttttta-
gaagaactattcag-3  and the reverse compliment primer was 5 -ctgaatagtt-
cttctaaaaaagccggtgatacatctataatgataccc-3 . All mutations were confirmed
by nucleotide sequencing (UTHSCSA DNA core facility).
In vitro transcriptions and oocyte protocols
Synthetic mRNA was prepared as described previously (Camacho and
Lechleiter, 1995). In brief, the pGEM-HeNot vector containing cDNA tem-
plate was linearized by a NotI restriction enzyme. From the linearized
templates, mRNA was generated using the T7 promoter (MEGAscript;
Ambion). Cap analogue, m
7G(5 )ppp(5”) (Ambion) was added to the re-
action. The mRNA products were quantified by 1% agarose gel and spec-
trophotometry. RNase-free synthetic RNAs were resuspended at a concen-
tration of 1.5–2.0  g/ l and stored in aliquots of 3  l at –80 C.
Stage VI oocytes were obtained from adult female Xenopus laevis.
After defolliculation, oocytes were incubated in MBS (in mM: 88 NaCl, 1
KCl, 0.41 CaCl2, 0.33 Ca(NO3)2, 0.82 MgSO4, 2.40 NaHCO3, 10
Hepes, pH 7.5) at 18 C. mRNA was injected into the oocytes by a 50-nL
bolus using a positive pressure injector (Nanoject; Drummond Scientific
Co.). Control oocytes were injected with diethyl pyrocarbonate–treated
water. Oocytes were incubated at 18 C for 2–3 d to allow full expression
of proteins in MBS supplemented with antibiotics streptomycin, penicillin,
and fungizone (GIBCO-BRL). Media was changed daily. Unhealthy oo-
cytes were discarded daily.
Imaging acquisition and analysis
Ca
2  wave activity was imaged as described previously (Camacho and
Lechleiter, 1995). In brief, oocytes were injected with 50 nl of a fluores-
cent Ca
2  sensitive dye (0.25 mM, Oregon green BAPTA2-cell imper-
meant; Molecular Probes) and incubated for 30–60 min before the exper-
iment. Images were acquired with a confocal laser-scanning microscope
(model PCM2000; Nikon) attached to an inverted microscope (model
TE200; Nikon) at the rate of 1.5 images/s. We used a 10  0.45 NA ob-
jective (UVFLUOR; Nikon). Each group of mRNA-injected oocytes was ran-
domly assigned into two subgroups, one was exposed to 100 nM of T3 for
10 min and the other was untreated with T3. Ca
2  wave activity was initi-
ated by injecting a 50-nl bolus of 6  M IP3. The Ca
2  waves were ana-
lyzed with ANALYZE software (The Mayo Foundation, Rochester, MN).
Statistical significance was calculated by either one-factor ANOVA or a t
test as indicated.
   was estimated as described previously (Lin and Lechleiter, 2002).
In brief, 200 nM TMRE (Molecular Probes) was added to the bath and im-
ages were acquired with a 60  1.4 NA objective on the Nikon PCM2000
custom adapted for two-photon imaging. TMRE was excited at 800 nm us-
ing a Ti-sapphire Coherent Mira 900 Laser pumped with a 5W Verdi laser
(Coherent Inc.). Laser intensity was attenuated with a neutral-density filter
wheel such that no detectable photobleaching of TMRE was observed.
Transcriptional activity assay
The transcriptional activity of TR and mutants were confirmed by using a
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hancer for the SEAP gene (Mercury Pathway Profiling SEAP System2;
CLONTECH Laboratories, Inc.). The negative control vector (pSEAP
( ve))
lacks the enhancer element, but contains a promoter and SEAP reporter
gene. Oocytes in each group were injected with mRNA (0.5  g) and vec-
tor (0.5  g) as designated, and incubated in 1 ml MBS with 100 nM T3,
and/or RA for 3 d. Media was collected and replaced every 24 h for 3 d.
Collected media from each group was pooled, concentrated (Amicon ultra
10000 MWCO; Millipore) to 40  l and run on a 10% SDS-PAGE. Oo-
cyte cytosolic extract from each group was prepared and loaded onto
10% SDS-PAGE at amounts equivalent to 2.5 oocytes per lane. SEAP was
detected with polyclonal rabbit anti–human SEAP antibody (Zymed Labo-
ratories, Inc.). HRP-conjugated secondary antibody (Jackson ImmunoRe-
search Laboratories Inc.) was used and visualized by chemiluminescence
(PerkinElmer).
Western blot analysis
Oocytes were washed twice times in homogenization buffer (in mM: 15
Tris-HCl, 140 NaCl, 250 sucrose, 1% Triton X-100, Complete protease in-
hibitor cocktail) at a concentration of 40  l/oocyte. Washed oocytes
were homogenized and centrifuged at 4,500 g for 15 min at 4 C. The su-
pernatant was collected and loaded at 0.5 oocytes per lane onto 10%
SDS-PAGE. TRs and mutants were detected with monoclonal mouse anti–
human TRs antibody (MA1-215; Affinity BioReagents, Inc.). xRXR  was de-
tected with polyclonal rabbit anti–human RXRs antibody (Sc-774; Santa
Cruz Biotechnology, Inc.). HRP-conjugated secondary antibody (Jackson
ImmunoResearch Laboratories Inc.) was used and visualized by chemilumi-
nescence (PerkinElmer).
Cytosolic and mitochondrial extract preparations
300 oocytes in each group (water, xTR A1, rTR 1, rTR 1 F) were allowed
to express for 3 d and then treated with 100 nM T3 for 15 min at RT. Oo-
cytes were washed twice times with buffer A (in mM: 190 sorbitol, 1
CaCl2, 10 TES, pH 7.4) and resuspended in buffer A at a final volume of
500  l. Oocytes were sequentially homogenized with a hand-held ho-
mogenizer and centrifuged at 1,000 g for 5 min at 4 C. The supernatant
was transferred to new tube and centrifuged at 14,000 g for 15 min at
4 C. Supernatant and pellet were collected separately. The pellet, which
contained mitochondria, was washed several times with buffer B (in mM:
195 sorbitol, 5 EDTA, 5 TES, pH 7.4) and spun at 1,000 g for 5 min at
4 C to eliminate contaminants. The mitochondrial portion was finally ob-
tained by centrifugation at 14,000 g for 15 min at 4 C. Mitochondria in
each group were washed twice by resuspending in buffer B, centrifuged
again at 14,000 g for 15 min at 4 C and lysed in the presence of 1% Tri-
ton X-100. The cytosolic fraction was centrifuged at 100,000 g for 15 min
at 4 C to eliminate contaminating membranes.
O2 consumption assay
A biological O2 monitor (model 5300; YSI Inc.) was used to measure O2
consumption. 200 oocytes in each group were loaded into a 2-ml O2
probe chamber avoiding contact of the oocytes with the O2 probe. 1.5 ml
of MBS was added to the chamber and the system was allowed to stabi-
lize for 15 min. The medium was subsequently exchanged with 1.25 ml of
fresh MBS solution and O2 consumption was monitored for 30 min. The
media was exchanged again with MBS containing 100 nM T3 and O2
consumption was followed for the next 30 min. The slope of O2 levels was
calculated before and after the addition of T3.
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